These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25394310)

  • 1. Neutrophilic dermatosis: disease mechanism and treatment.
    Maalouf D; Battistella M; Bouaziz JD
    Curr Opin Hematol; 2015 Jan; 22(1):23-9. PubMed ID: 25394310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two neutrophilic dermatoses and one multiple myeloma : A case report].
    Wolfsperger F; Müller A; Kofler L; Yazdi A
    Hautarzt; 2019 Jul; 70(7):527-529. PubMed ID: 30937480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome.
    Kluger N; Gil-Bistes D; Guillot B; Bessis D
    Dermatology; 2011; 222(2):123-7. PubMed ID: 21464561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses.
    Wallach D; Vignon-Pennamen MD
    Br J Dermatol; 2018 Mar; 178(3):595-602. PubMed ID: 26202386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research.
    Wallach D; Vignon-Pennamen MD
    J Am Acad Dermatol; 2006 Dec; 55(6):1066-71. PubMed ID: 17097401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophilic dermatoses as systemic diseases.
    Prat L; Bouaziz JD; Wallach D; Vignon-Pennamen MD; Bagot M
    Clin Dermatol; 2014; 32(3):376-88. PubMed ID: 24767185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of pyoderma gangrenosum and sweet's syndrome in a patient with ulcerative colitis.
    Ajili F; Souissi A; Bougrine F; Boussetta N; Abdelhafidh NB; Sayhi S; Louzir B; Doss N; Laabidi J; Othmani S
    Pan Afr Med J; 2015; 21():151. PubMed ID: 26327988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of neutrophilic dermatoses.
    Schadt CR; Callen JP
    Dermatol Ther; 2012; 25(2):158-72. PubMed ID: 22741935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases].
    Lipsker D; Lenormand C
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):459-67. PubMed ID: 22721478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Therapeutic Approaches and Targets for the Treatment of Neutrophilic Dermatoses, Management of Patients with Neutrophilic Dermatoses and Future Directions in the Era of Biologic Treatment.
    Molinelli E; Brisigotti V; Paolinelli M; Offidani A
    Curr Pharm Biotechnol; 2021; 22(1):46-58. PubMed ID: 32359335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neutrophilic dermatosis of the hands].
    Brajon D; Cuny JF; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011 Oct; 138(10):673-6. PubMed ID: 21978504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatic resolution of disseminated pyoderma gangrenosum associated with monoclonal gammopathy after therapy with bortezomib and dexamethasone.
    Velasco-Tamariz V; Carreño-Tarragona G; Tous-Romero F; Gil-de la Cruz E; Martín-Clavero E; Rivera-Díaz R
    Int Wound J; 2017 Dec; 14(6):1382-1384. PubMed ID: 28371346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pyoderma gangrenosum and Sweet's syndrome : Cutaneous manifestations of autoinflammatory disorders].
    Meier B; Maul JT; French LE
    Hautarzt; 2016 Dec; 67(12):934-939. PubMed ID: 27796411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
    Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
    Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet's syndrome: the concept of neutrophilic disease.
    Caucanas M; Heylen A; Rolland F; Müller G; Olemans C; Sass U; Vanhooteghem O
    Int J Dermatol; 2013 Oct; 52(10):1185-8. PubMed ID: 24073904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Review of Neutrophilic Diseases.
    Marzano AV; Borghi A; Wallach D; Cugno M
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):114-130. PubMed ID: 28688013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyoderma gangrenosum, subcorneal IgA pustulosis and recurrent neutrophilic pleural and pulmonary diseases in a patient with IgA gammopathy].
    Cartier H; Plantin P; Leroy JP; Larzul JJ
    Ann Dermatol Venereol; 1995; 122(3):97-101. PubMed ID: 7486731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophilic dermatoses and inflammatory bowel diseases.
    Marzano AV; Menicanti C; Crosti C; Trevisan V
    G Ital Dermatol Venereol; 2013 Apr; 148(2):185-96. PubMed ID: 23588144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophilic dermatoses: pyoderma gangrenosum and Sweet's syndrome.
    Lear JT; Atherton MT; Byrne JP
    Postgrad Med J; 1997 Feb; 73(856):65-8. PubMed ID: 9122099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.